Exclusive Labor Day Discount 20% OFF EVERYTHING. Code LABOR20 at checkout. Ends Friday.

Research

Peptides vs SARMs: Why They Are Not the Same Category

By The Precision Peptide Company

Key takeaways

  • Peptides are chains of amino acids. SARMs are non-steroidal small molecules built to bind the androgen receptor. Different classes of compound entirely.
  • FDA says SARMs are not dietary ingredients, and reported harms include liver injury requiring hospitalisation.
  • Peptides have an active regulatory pathway. In July 2026 an FDA advisory committee recommended six peptides for the Section 503A Bulks List. There's no equivalent process for SARMs.
  • Both are prohibited in various forms under anti-doping rules. Legal status and sporting eligibility are separate questions.
  • The two get confused because the same gray-market vendors sell both, not because they have anything in common.

Why this comparison keeps coming up

Search volume for "peptides vs SARMs" is high, and the reason isn't chemistry. It's retail.

For most of the last decade, both were sold through the same channels. Unbranded websites, "research use only" labelling, forum recommendations, and social accounts aimed squarely at the fitness market. If you came across one, you likely came across the other usually on the same page.

That shared shopfront created a shared reputation. It shouldn't have. On the science and on the law, these are separate categories with separate risk profiles, and it's worth understanding why.

What a peptide is

A peptide is a short chain of amino acids joined by peptide bonds. Amino acids are the same building blocks that make up the protein in your food. By convention, chains of around 50 amino acids or fewer get called peptides, and longer chains get called proteins.

Peptides act as signalling molecules throughout the body. Insulin, glucagon and oxytocin are all peptide hormones.⁸

Commercially, peptides fall into three distinct groups: peptide ingredients in dietary supplements, peptides compounded by licensed pharmacies against a prescription, and research chemicals sold with "not for human use" labelling. Those three carry very different levels of oversight, and lumping them together causes as much confusion as lumping peptides in with SARMs.

What a SARM is

A selective androgen receptor modulator isn't a peptide and shares no structural relationship with one.

SARMs are synthetic non-steroidal small molecules developed to bind the androgen receptor, the same receptor testosterone acts on, with the goal of producing tissue-selective anabolic effects. FDA describes them as chemical substances that mimic the effects of testosterone and anabolic steroids.[2] They're sold under names like ostarine and andarine, very often on labels dressed up as dietary supplements.

That packaging is a problem. FDA's position leaves no room for interpretation. Although these products are generally marketed as dietary supplements, they are not dietary supplements. They're unapproved drugs that FDA hasn't reviewed for safety and effectiveness.

The regulatory picture, side by side

Where SARMs stand

FDA has issued warning letters to companies distributing SARM-containing products and has pursued criminal action against distributors.1,10 Its consumer guidance is blunt: people should not use these products.

The agency has documented reported harms including life-threatening reactions and liver injuries requiring hospitalisation, and lists potential effects including increased risk of heart attack or stroke, psychosis and hallucinations, sleep disturbance, sexual dysfunction, liver injury and acute liver failure, infertility, pregnancy miscarriage and testicular shrinkage.1,2

FDA has also warned specifically about social media promotion of SARMs to teenagers and young adults, noting it continues to receive adverse event reports.2 The major dietary supplement trade associations and USADA have publicly backed that enforcement position.

There's no regulatory pathway currently moving SARMs toward legitimate consumer or compounded availability. 

Where peptides stand

In 2023, FDA placed a group of peptides into Category 2 of the bulk drug substances list, which stopped compounding pharmacies using them. In April 2026, seven of those were removed from Category 2 and sent for advisory committee review.

On 23 and 24 July 2026, FDA's Pharmacy Compounding Advisory Committee recommended six of the seven for the Section 503A Bulks List: BPC-157, KPV, TB-500, MOTS-c, Semax and epitalon. Emideltide, also called DSIP, was voted down.4,5

Three things to keep straight, because plenty of coverage didn't. These were recommendations, not approvals. FDA still has to complete formal rulemaking, realistically into 2027. And the committee voted against its own agency's scientific reviewers, who'd cited short, underpowered studies and limited human trial data.

Separately and importantly, peptide ingredients used in dietary supplements sit under a completely different framework, the Dietary Supplement Health and Education Act, and weren't affected by the compounding decision at all.

The contrast that matters: Peptides are a category being actively evaluated for legitimate regulated supply. Peptides are a category being actively evaluated within specific regulated pathways. By contrast, FDA has repeatedly warned that SARMs marketed for human use are unapproved drugs and cannot legally be marketed as dietary supplements.¹˒²

Mechanism: a signal versus a receptor being occupied

This is the part that explains why the two behave so differently in the body.

SARMs are designed to occupy the androgen receptor. That receptor is expressed widely, including in the liver and cardiovascular system, which is exactly why the reported harm profile is systemic and includes hepatic and cardiovascular events. Clinical studies of some SARMs have reported suppression of endogenous testosterone and related hormonal changes.⁹

Peptides generally act as signals inside existing physiological pathways, often at very low concentrations and often on narrow targets. KPV, for example, is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone that modulates inflammatory signalling in preclinical models without engaging the melanocortin receptors responsible for pigmentation.[6]

That's a design philosophy difference. It is not a claim that peptides are risk free. Plenty of peptides have limited human safety data, which is precisely what FDA reviewers argued in July 2026. But "under-studied" and "documented to cause acute liver failure" are not the same.

Anti-doping: both matter, for different reasons

If you compete under a body that follows the WADA Code, none of the above decides your eligibility.

SARMs are prohibited under the anabolic agents class of the WADA Prohibited List.7 USADA notes SARM ingredients can appear on labels under a range of names, and that many products advertising SARM content show up on high-risk supplement lists. SARMs are prohibited under the anabolic agents class of the WADA Prohibited List.⁷ USADA notes that SARM ingredients can appear on labels under a range of names and that SARM-containing products may appear on high-risk supplement lists.³

Several peptide classes are also prohibited, including growth hormone secretagogues and various peptide hormones. Some peptides aren't. The only sensible approach is to check the current Prohibited List and use a certified supplement testing programme.[7] Never treat legal availability as proof something is permitted in sport.

How to tell what you're actually looking at

  • Check the compound class. If it's described as an androgen receptor modulator, or sits alongside ostarine, andarine, ligandrol or RAD-140, it's a SARM regardless of what the packaging says.
  • Ignore the "research use only" framing. It appears on products in both categories. It's not a quality signal.
  • Treat physique-transformation marketing as a warning. FDA's warnings specifically call out social media promotion promising quick appearance or muscle-mass gains.
  • Ask which regulatory bucket a product sits in. A legitimate seller can tell you instantly whether something is a dietary supplement, a compounded prescription preparation, or a research chemical.
  • Report adverse events. FDA's MedWatch programme takes consumer reports, and that's how patterns in this category get spotted.

Frequently asked questions

Are peptides SARMs? No. Peptides are chains of amino acids that act as signalling molecules. SARMs are non-steroidal small molecules that bind the androgen receptor. Unrelated classes of compound.

Are SARMs legal? FDA's position is that SARMs aren't legitimate dietary ingredients and that products containing them are unapproved drugs.1,2 The agency has issued warning letters and pursued criminal action against distributors.

Are peptides safer than SARMs? They carry different risk profiles. FDA has documented serious harms linked to SARM-containing products, including liver injury requiring hospitalisation.[1] For many peptides the issue is different: limited long-term human safety data rather than documented acute harm. Neither point means any specific product is safe.

Are peptides banned in sport? Some are. Several peptide classes appear on the WADA Prohibited List, and SARMs are prohibited as anabolic agents.[7] Check the current list rather than assuming.

Why are peptides and SARMs sold on the same websites? Because both were historically distributed through gray-market channels using "research use only" labelling. That's a distribution overlap, not a scientific or regulatory similarity.

References

  1. FDA. Certain bodybuilding products put consumers at risk.
  2. FDA. FDA warns of use of selective androgen receptor modulators (SARMs) among teens, young adults.
  3. U.S. Anti-Doping Agency. Selective androgen receptor modulators (SARMs).
  4. FDA. Pharmacy Compounding Advisory Committee meeting, 23-24 July 2026.
  5. American Journal of Managed Care. FDA panel backs 6 peptides for compounding.
  6. Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 2008.
  7. World Anti-Doping Agency. Prohibited List.
  8. Forbes Kaprive J, Krishnamurthy K. Biochemistry, Peptide. StatPearls.
  9. Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sexual Medicine Reviews. 2019;7(1):84–94.
  10. FDA. Nampa Man Pleads Guilty to Federal Felony for Selling Over $4.4 Million in Unapproved Steroid-Like Drugs.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. This article is for general information only and is not medical advice.